Pingxiang People's Hospital — Pingxiang, Jiangxi

Public research footprint of Pingxiang People's Hospital, compiled from the ClinicalTrials.gov public registry.

129

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

T2DM (Type 2 Diabetes Mellitus) · Arthritis, Psoriatic · Heart Failure · Metabolic Dysfunction Associated Steatohepatitis (MASH)

Recently updated registry entries

NCT07242300 — Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection in the… (Recruiting)
NCT05878769 — A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic… (Recruiting)
NCT06415773 — Effects of Berberine Ursodeoxycholate (HTD1801) Versus Dapagliflozin in Patients With… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Pingxiang People's Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.